CompoAtlas

Curcumaxx Boswellia bio 60 gélules

Food supplement declared in France, declaration No 2019-5-533

Curcumaxx Boswellia bio 60 gélules, from CURCUMAXX FRANCE, is a food supplement declared in France. Status: withdrawn from the market on 9 October 2022. Main ingredients: Boswellia serrata 770 mg per day. None of the rules we check flags an issue with its declared composition.

Brand
CURCUMAXX
Food business operator placing the product on the market
CURCUMAXX FRANCE
Status
Withdrawn from the market on 9 October 2022
Form
Capsule
Daily dose
2 gélules
Directions for use
2 gélules par jour
Not recommended (according to the manufacturer)
Breastfeeding women, Taking anticoagulants
Objectives stated by the manufacturer (these are not authorised claims)
Antioxidant, Respiratory tract

Declaration 295498, procedure Article 15. Compl'Alim, food supplement declarations (France), retrieved 15 November 2026.

Declared composition

Plants

PlantPartPreparationPer day
Boswellia serrata Roxb. ex Colebr.ResinDry aqueous extract770 mg

The evidence date of this ingredient list is unknown.

Has the product changed? Photograph the packaging.

Label warnings

l'emploi chez les personnes sous anti-coagulant est déconseillé

Regulatory points

This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.

Brand : CURCUMAXX

Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.

Cite this page: CompoAtlas, “Curcumaxx Boswellia bio 60 gélules: composition and regulation”, https://compoatlas.com/en/supplements/products/295498-curcumaxx-boswellia-bio-60-gelules, updated 15 November 2026.

Enter to analyse, Shift+Enter for a new line